Peptide deformylase (PDF) is considered an excellent target to develop antibiotics. We have performed an extensive characterization of a new PDF from the pathogen Streptococcus agalactiae, showing properties similar to other known PDFs. S. agalactiae PDF could be used as PDF prototype as it allowed to get complete sets of 3-dimensional, biophysical and kinetic data with virtually any inhibitor compound. Structure-activity relationship analysis with this single reference system allowed us to reveal distinct binding modes for different PDF inhibitors and the key role of a hydrogen bond in potentiating the interaction between ligand and target. We propose this protein as an irreplaceable tool, allowing easy and relevant fine comparisons between series, to design, challenge and validate novel series of inhibitors. As proof-of-concept, we report here the design and synthesis of effective specific bacterial PDF inhibitors of an oxadiazole series with potent antimicrobial activity against a multidrug resistant clinical isolate.
multidrug resistant 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Multiple_drug_resistance

single                        0.8590944696851013^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Single_(music)        

biophysical                   0.9999883016739524^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Biophysics            

S. agalactiae                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Streptococcus_agalactiae

Structure-activity relationship1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Structureâ€“activity_relationship

inhibitor                     0.9999999986712282^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

kinetic                       0.5941429409498556^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_kinetics       

PDFs                          0.9908445101457316^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Portable_Document_Format

protein                       0.9999752092470546^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

irreplaceable                 0.9999999999870397^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Irreplaceable         

PDF                           0.9969146942018371^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Portable_Document_Format

PDF                           0.9969146942018371^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Portable_Document_Format

pathogen                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pathogen              

antimicrobial                 0.9999938338377458^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Antimicrobial         

bacterial                     0.9999999999985221^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Bacteria              

prototype                     0.9926308709663466^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Prototype             

compound                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemical_compound     

Streptococcus agalactiae      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Streptococcus_agalactiae

hydrogen bond                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

ligand                        0.940573988226955^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Ligand                

PDF                           0.9969146942018371^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Portable_Document_Format

antibiotics                   0.9848239148120417^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Antibacterial         

Peptide deformylase           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Peptide_deformylase   

inhibitors                    0.9999999999976126^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

PDF                           0.9969146942018371^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Portable_Document_Format

inhibitors                    0.9999999999976126^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

inhibitors                    0.9999999999976126^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

oxadiazole                    0.9999999037924046^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Oxadiazole            

PDF                           0.9969146942018371^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Portable_Document_Format

PDF                           0.9969146942018371^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Portable_Document_Format

dimensional                   0.8262697939887409^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Dimension_(mathematics_and_physics)

proof-of-concept              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Proof_of_concept      

